Advancing personalized medicine in digital health: The role of artificial intelligence in enhancing clinical interpretation of 24-h ambulatory blood pressure monitoring

推进数字健康领域的个性化医疗:人工智能在增强24小时动态血压监测临床解读中的作用

阅读:1

Abstract

Background: The use of artificial intelligence (AI) for interpreting ambulatory blood pressure monitoring (ABPM) data is gaining traction in clinical practice. Evaluating the accuracy of AI models, like ChatGPT 4.0, in clinical settings can inform their integration into healthcare processes. However, limited research has been conducted to validate the performance of such models against expert interpretations in real-world clinical scenarios. Methods: A total of 53 ABPM records from Mayo Clinic, Minnesota, were analyzed. ChatGPT 4.0's interpretations were compared with consensus results from two experienced nephrologists, based on the American College of Cardiology/American Heart Association (ACC/AHA) guidelines. The study assessed ChatGPT's accuracy and reliability over two rounds of testing, with a three-month interval between rounds. Results: ChatGPT achieved an accuracy of 87% for identifying hypertension, 89% for nocturnal hypertension, 81% for nocturnal dipping, and 94% for abnormal heart rate. ChatGPT correctly identified all conditions in 60% of ABPM records. The percentage agreement between the first and second round of ChatGPT's analysis was 81% in identifying hypertension, 85% in nocturnal hypertension, 89% in nocturnal dipping, and 94% in abnormal heart rate. There was no significant difference in accuracy between the first and second round (all p > 0.05). The Kappa statistic was 0.63 for identifying hypertension, 0.66 for nocturnal hypertension, 0.76 for nocturnal dipping, and 0.70 for abnormal heart rate. Conclusions: ChatGPT 4.0 demonstrates potential as a reliable tool for interpreting 24-h ABPM data, achieving substantial agreement with expert nephrologists. These findings underscore the potential for AI integration into hypertension management workflows, while highlighting the need for further validation in larger, diverse cohorts.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。